A Possible Association Between Rituximab and the Subsequent Development of Guillain-Barré Syndrome: A Case Report

Lilian Chen1, Stephen Lee Yu2, Nolan Holley1

  • 1Department of Internal Medicine, West Virginia University, Morgantown, WV 26506, USA.

Reports (MDPI)
|August 22, 2025
PubMed
Summary

Diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab may develop Guillain-Barré syndrome (GBS). Early recognition of this rituximab-induced GBS is crucial for prompt treatment and improved patient outcomes.